Award
NIH Reporter #5R01EY024280-13
Engineering AAV for safe and efficient gene delivery to the human retina
Recipient
National Eye Institute (NEI), part of the NIH
Award Amount
$638,000.00
Ceiling
$638,000.00
Awarded
September 01, 2026
Identifier
5R01EY024280-13
NIH grant awarded to develop safe and efficient AAV vectors for retinal gene therapy, managed by the National Eye Institute, with a project duration from 2014 to 2029 and an award amount of approximately $638,000 for FY 2026.
Description
This NIH-funded project focuses on advancing gene therapy for retinal diseases using engineered AAV vectors, with significant implications for treating inherited and age-related retinal conditions. The project aims to develop novel Adeno associated viral (AAV) vectors for retinal gene therapy involving preclinical studies in macaques to improve safety and transduction efficiency.